The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

A mum-of-four told her husband she loved him before she went to sleep and never woke up. Deanne Clarke, 41, was described by ...

But a new genetic test appears capable of sussing out which men are at greater risk of urinary side effects from radiation ...

Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

Ireland based, US stock market listed, Icon PLC has been accused of engaging in a “scheme to deceive the market” as a huge US ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax to Present Clinical Data at Upcoming April Industry Events 15.04.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of ...

Avidity's delpacibart etedesiran (del-desiran) was granted orphan drug status in Japan as a treatment for myotonic dystrophy ...

Global Clinical Trial Expansion and Rising Chronic Disease Burden Fuel Demand for Specialized CRO ServicesDublin, April 15, 2025 (GLOBE NEW ...

A dad thought "my life's over" when he was given a devastating diagnosis. Paul Swift, 40, was just four weeks off running his ...

"A colonoscopy confirmed it was cancer and I thought ‘oh my god, my life’s over’. My daughter was only three-years-old, so ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...